Top 410 Therapeutics Mid Stage Investors in United States

Last Updated: May 2024

A curated list of 410 Angel Investors and VC funds that invests in Therapeutics startups located in United States. Investors are ranked based on the number of investments they made worldwide.

Industry

Therapeutics

Location

United States

Investment Stage

Mid Stage

Include Only Business Angels?

Only include Company Founders?

410 Investors Matched (410 LinkedIn, 255 Emails, 121 Twitter)

Will Griffith - Founding Partner at ICONIQ Growth

Founding Partner at ICONIQ Growth

early stage: 15 / mid stage: 49 / late stage : 39

J C. - Venture Capital Investor, Entrepreneur, Engineer

Venture Capital Investor, Entrepreneur, Engineer

early stage: 32 / mid stage: 28 / late stage : 6

Rany Raviv - Co Founder @ The R-Group, LLC

Co Founder @ The R-Group, LLC

early stage: 35 / mid stage: 14 / late stage : 12

Helen Liang, PhD - Founder & Managing Partner of FoundersX Ventures. Featured on WSJ and Business Insider as a Pioneering Tech VC. Board Director. Invited Speaker at TechCrunch. Support AGI House SF Hackathons.

Founder & Managing Partner of FoundersX Ventures. Featured on WSJ and Business Insider as a Pioneering Tech VC. Board Director. Invited Speaker at TechCrunch. Support AGI House SF Hackathons.

early stage: 41 / mid stage: 10 / late stage : 4

Ryan Gembala - Managing Partner & Founder @ Pathbreaker Ventures

Managing Partner & Founder @ Pathbreaker Ventures

early stage: 43 / mid stage: 3 / late stage : 1

David Langer - Founding Partner at Lionheart Ventures

Founding Partner at Lionheart Ventures

early stage: 31 / mid stage: 14 / late stage : 2

Ludwig Pierre Schulze - Managing Partner @ Alumni Ventures

Managing Partner @ Alumni Ventures

early stage: 26 / mid stage: 12 / late stage : 8

Oded Hermoni - Managing Partner - J-Ventures VC Group, Silicon Valley ( J-Ventures, J-Impact, J-Angels). Former partner at Rhodium and Coin Ventures and head of Israeli VC industry association and Israeli tech ( Now IATI)

Managing Partner - J-Ventures VC Group, Silicon Valley ( J-Ventures, J-Impact, J-Angels). Former partner at Rhodium and Coin Ventures and head of Israeli VC industry association and Israeli tech ( Now IATI)

early stage: 24 / mid stage: 11 / late stage : 8

Scott Kosch - Advisor and Investor

Advisor and Investor

early stage: 32 / mid stage: 9 / late stage : 3

Caroline Farah Lembck, MBA, PhD (abd) - CEO & Head of LemVega Capital | Expert in Investment Management, Business Strategy, and Specialized Biotech Venture Capital & Multi-Strategy Hedge Funds

CEO & Head of LemVega Capital | Expert in Investment Management, Business Strategy, and Specialized Biotech Venture Capital & Multi-Strategy Hedge Funds

early stage: 1 / mid stage: 4 / late stage : 15